$3.1M NCI award fuels canine cancer research as model for rare human cancer
The five-year grant prioritizes impactful translational research on canine hemangiosarcoma and angiosarcoma in humans.
The five-year grant prioritizes impactful translational research on canine hemangiosarcoma and angiosarcoma in humans.
Drs. Elias Sayour and Rowan Milner work with dog patients to develop treatments that may one day heal humans with brain and bone tumors.
UF Health Cancer Institute scientists are teaming up with experts at The Wertheim UF Scripps Institute to target cancer’s biological mysteries and seek potential drug leads for many cancer types.
For the first time, researchers have performed comprehensive genomic profiling of angiosarcoma cells.
Researchers have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma.
A young French bulldog’s battle with an extremely rare and aggressive cancer has broken new ground in veterinary oncology at the University of Florida, and the beloved pet’s treatment could lead to better cancer care for dogs and children.
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.